National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 7) (PB 86 of 2020) (Cth)

PB 86 of 2020

National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 7)

I, Thea Daniel, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make the following Determination.

Dated   26        August 2020               

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)              2

1  Name

This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 7).

This instrument may also be cited as PB 86 of 2020

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	I September 2020.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under section 85B of the National Health Act 1953

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

1  Schedule 1, entry for Ciprofloxacin

Omit

Ciprofloxacin	Eye drops 3 mg (as hydrochloride) per mL, 5 mL	Application to the eye	Ciloxan	1	8.92	10.95
Tablet 500 mg (as hydrochloride)	Oral	Ciproxin 500	14	5.82	10.08

Substitute

Ciprofloxacin Eye drops 3 mg (as hydrochloride) per mL, 5 mL Application to the eye Ciloxan 1 8.92 10.95

2  Schedule 1, entry for Metformin

Omit

Metformin	Tablet containing metformin hydrochloride 500 mg	Oral	Diabex	100	2.50	7.11
Tablet (extended release) containing metformin hydrochloride 500 mg	Oral	Diabex XR	120	4.01	8.61
Tablet containing metformin hydrochloride 850 mg	Oral	Diabex 850	60	2.50	7.11
Tablet containing metformin hydrochloride 1 g	Oral	Diabex 1000	90	4.36	8.97
Tablet (extended release) containing metformin hydrochloride 1 g	Oral	Diabex XR 1000	60	4.01	8.61

Substitute

Metformin	Tablet containing metformin hydrochloride 500 mg	Oral	Diabex	100	2.50	7.11
Tablet (extended release) containing metformin hydrochloride 500 mg	Oral	Diabex XR 500	120	4.01	8.61
Tablet containing metformin hydrochloride 850 mg	Oral	Diabex 850	60	2.50	7.11
Tablet containing metformin hydrochloride 1 g	Oral	Diabex 1000	90	4.36	8.97
Tablet (extended release) containing metformin hydrochloride 1 g	Oral	Diabex XR 1000	60	4.01	8.61

3  Schedule 1, omit entry for Nifedipine

4  Schedule 1, entry for Salbutamol

Omit

Salbutamol	Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20	Inhalation	Ventolin Nebules	20	2.48	4.04
Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30	Inhalation	Asmol 2.5 uni‑dose	1	3.72	3.95
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20	Inhalation	Ventolin Nebules	1	2.61	4.16
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30	Inhalation	Asmol 5 uni-dose	1	3.92	4.15
Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)	Inhalation by mouth	Ventolin CFC-free	1	3.90	5.60
Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)	Inhalation by mouth	Ventolin	1	4.49	6.82

Substitute

Salbutamol	Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20	Inhalation	Ventolin Nebules	20	2.48	4.04
Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30	Inhalation	Asmol 2.5 uni‑dose	1	3.72	3.95
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20	Inhalation	Ventolin Nebules	1	2.61	4.16
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30	Inhalation	Asmol 5 uni-dose	1	3.92	4.15
Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)	Inhalation by mouth	Ventolin CFC-free	1	3.90	5.60
Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)	Inhalation by mouth	Ventolin CFC-Free with dose counter	1	4.49	6.82